Stay updated with breaking news from Bart Clarke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Oral presentation of results showed sustained improvements through Week 52, as well as safety and tolerability similar to that previously reported for the initial 26-week blinded... | June 18, 2023
- Oral presentation of results showed sustained improvements through Week 52, as well as safety and tolerability similar to that previously reported for the initial 26-week blinded portion of the Phase 3 PaTHway Trial -
An osteoporosis risk factor when used long-term, steroids help relieve pain in chronic diseases such as rheumatoid arthritis, ulcerative colitis, and atopic dermatitis. Here's how to minimize risks.
(2022-06-07 | NDAQ:ASND) Ascendis Pharma A/S Announces Two Oral Presentations Highlighting the Potential for TransCon(TM) PTH to be a Replacement Therapy for Adult Hypoparathyroidism at ENDO 2022
– Late-breaker oral presentation of TransCon PTH Phase 3 PaTHway Trial data in adult hypoparathyroidism on Tuesday, June 14 – Oral presentation of...